About the Product

Description


Uriviga 0.2 Tablet contains Tamsulosin 0.2mg, a selective alpha-1 adrenergic receptor blocker used for the management of benign prostatic hyperplasia (BPH). It helps in relieving lower urinary tract symptoms such as difficulty in urination, weak stream, and frequent urination.

Tamsulosin works by relaxing smooth muscles in the prostate and bladder neck, improving urine flow and reducing urinary retention. This targeted mechanism ensures symptomatic relief and better quality of life for patients with BPH.

This tablet is commonly prescribed for chronic management of BPH and is particularly useful in older male patients who require long-term therapy. Its oral dosage ensures convenient administration and better patient compliance.

For PCD pharma franchise partners, Uriviga 0.2 Tablet is a high-demand urology product, available at the best price for PCD pharma franchise. Its proven clinical efficacy, consistent prescription trends, and strong patient demand make it a valuable addition to any urology or prostate care product portfolio.


Common side effects may include dizziness, headache, mild fatigue, and nasal congestion. Rare but serious side effects include severe hypotension, fainting, or allergic reactions. Patients should report severe or persistent symptoms to their doctor.

Uriviga 0.2 Tablet is indicated for the treatment of lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia, including difficulty in urination, weak urine stream, and urinary frequency.

Uriviga 0.2 Tablet should be taken exactly as prescribed, usually 30 minutes after the same meal each day. Caution is advised in patients with low blood pressure, liver disease, or a history of heart problems. Avoid sudden position changes to prevent dizziness or fainting.

Store Uriviga 0.2 Tablet in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children and do not use after the expiry date printed on the packaging.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Tamsulosin 0.2mg Tablet in the PCD pharma franchise market?

Tamsulosin 0.2mg Tablet has strong demand in the urology, men's healthcare, and chronic care segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on urology and specialty healthcare portfolios.

Why should medical distributors include Tamsulosin 0.2mg Tablet in their product range?

Medical distributors and agencies can benefit from consistent demand for benign prostatic hyperplasia (BPH) management under medical supervision. Tamsulosin 0.2mg is an alpha-1 adrenergic blocker that helps relax the muscles of the prostate and bladder neck Commonly prescribed for the management of benign prostatic hyperplasia (BPH) or enlarged prostate as advised by healthcare professionals Helps improve urinary flow and reduce symptoms such as difficulty in urination, weak urine stream, urinary urgency, urinary frequency, and nocturia Supports better bladder emptying and improves quality of life in patients with lower urinary tract symptoms associated with BPH Frequently used as part of long-term urological care and symptom management Widely prescribed by urologists, physicians, and general practitioners This strengthens a comprehensive urology and men's healthcare portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this product?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Tamsulosin 0.2mg Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from strong prescription demand in urology practice, long-term therapy usage, repeat orders, reliable supply chain support, and attractive margins in the men's healthcare segment.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, and wholesalers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality pharmaceutical products, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.